Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 4687-37-0 | MDL No. : | MFCD03424826 |
Formula : | C13H16O5 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | BHSYONGONOKNAI-UHFFFAOYSA-N |
M.W : | 252.26 | Pubchem ID : | 2758465 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.38 |
Num. rotatable bonds : | 7 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 65.33 |
TPSA : | 61.83 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.46 cm/s |
Log Po/w (iLOGP) : | 2.53 |
Log Po/w (XLOGP3) : | 1.94 |
Log Po/w (WLOGP) : | 1.84 |
Log Po/w (MLOGP) : | 1.02 |
Log Po/w (SILICOS-IT) : | 2.46 |
Consensus Log Po/w : | 1.96 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.41 |
Solubility : | 0.979 mg/ml ; 0.00388 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.86 |
Solubility : | 0.346 mg/ml ; 0.00137 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.49 |
Solubility : | 0.0811 mg/ml ; 0.000321 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.1 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76% | With sodium hydride In toluene; mineral oil | General procedure: The substrate b-ketoesters 10 a–n were either purchased or synthesized following published procedures. Some benzoylacetates were commercially available. Ethyl 3-oxo-3-phenyl propanoate (10a) was purchased. The reaction of benzoylacetates 10 b–n was prepared as described in previous reports. 25–27 A solution of a substituted acetophenone 8 a–n (0.05 mol) dissolved in toluene (50 mL) was added dropwise to a solution containing diethyl carbonate (9) (0.10 mol) and sodium hydride (0.15 mol 60percent dispersion in mineral oil). The mixture was stirred at room temperature, and then refluxed for 30 min. The mixture was poured into ice water,acidified with glacial acetic acid, and extracted with EtOAc (3x100 mL). The EtOAc extract was then dried over anhydrous MgSO4. After removal of the solvent in vacuo, the crude products were purified by silica gel column chromatography eluting with dichloromethane to afford benzoylacetates 10 b–n. All synthetic compounds were in agreement with 1H NMR, 13C NMR, IR and mass spectroscopic data. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | Stage #1: With pyridine In dichloromethane at -5 - 0℃; for 0.5 h; Stage #2: at -5 - 25℃; for 1.5 h; |
[Reference Example 1] Ethyl 3-(3,4-dimethoxyphenyl)-3-oxopropionate To a solution of 2,2-dimethyl-1,3-dioxane-4,6-dione (14.4 g 10 mmol) in dichloromethane (30 mL), pyridine (0.81 mL, 10 mmol) was added at 0°C or less, and this was stirred at -5°C for 0.5 hours. Subsequently, 3,4-dimethoxybenzoylchloride (2.00 g 10 mmol) was added at 0°C or less, stirred at -5°C for 0.5 hours, 0°C for 0.5 hours, and 25°C for 0.5 hours, and then 1 M hydrochloric acid (30 mL) was added while cooling on ice. This was then extracted with dichloromethane. After drying over magnesium sulfate, dichloromethane was distilled off, this was redissolved in ethanol (30 mL), refluxed for 1.5 hours, stirred at room temperature for 10 hours. It was then stirred at 60°C for 14 hours, ethanol was distilled off, and this was purified by silica gel column chromatography (elude: hexane: tetrahydrofuran = 3:1) which resulted in a colorless oily material (2.27 g, 90percent yield). |
[ 2881-83-6 ]
Ethyl (4-Methoxybenzoyl)acetate
Similarity: 0.95
[ 41607-95-8 ]
Ethyl (2-methyoxybenzoyl)acetate
Similarity: 0.91
[ 18066-68-7 ]
Ethyl 2-(3,4-dimethoxyphenyl)acetate
Similarity: 0.84
[ 3153-44-4 ]
4-(4-Methoxyphenyl)-4-oxobutanoic acid
Similarity: 0.84
[ 2107-69-9 ]
5,6-Dimethoxy-2,3-dihydro-1H-inden-1-one
Similarity: 0.80
[ 2881-83-6 ]
Ethyl (4-Methoxybenzoyl)acetate
Similarity: 0.95
[ 41607-95-8 ]
Ethyl (2-methyoxybenzoyl)acetate
Similarity: 0.91
[ 18066-68-7 ]
Ethyl 2-(3,4-dimethoxyphenyl)acetate
Similarity: 0.84
[ 3153-44-4 ]
4-(4-Methoxyphenyl)-4-oxobutanoic acid
Similarity: 0.84
[ 2107-69-9 ]
5,6-Dimethoxy-2,3-dihydro-1H-inden-1-one
Similarity: 0.80
[ 2881-83-6 ]
Ethyl (4-Methoxybenzoyl)acetate
Similarity: 0.95
[ 41607-95-8 ]
Ethyl (2-methyoxybenzoyl)acetate
Similarity: 0.91
[ 18066-68-7 ]
Ethyl 2-(3,4-dimethoxyphenyl)acetate
Similarity: 0.84
[ 81581-27-3 ]
Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-3-oxopropanoate
Similarity: 0.83
[ 93097-22-4 ]
Ethyl 7-methoxy-4-oxo-4H-chromene-3-carboxylate
Similarity: 0.80
[ 2881-83-6 ]
Ethyl (4-Methoxybenzoyl)acetate
Similarity: 0.95
[ 41607-95-8 ]
Ethyl (2-methyoxybenzoyl)acetate
Similarity: 0.91
[ 3153-44-4 ]
4-(4-Methoxyphenyl)-4-oxobutanoic acid
Similarity: 0.84
[ 81581-27-3 ]
Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-3-oxopropanoate
Similarity: 0.83
[ 2107-69-9 ]
5,6-Dimethoxy-2,3-dihydro-1H-inden-1-one
Similarity: 0.80